StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report published on Wednesday morning. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens upped their price target on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
Get Our Latest Analysis on Veradigm
Veradigm Stock Performance
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Must-Have ETFs Set to Dominate This Quarter
- Insider Trading – What You Need to Know
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How Investors Can Find the Best Cheap Dividend Stocks
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
